Finding better ways to diagnose and treat rheumatic diseases

The Division of Rheumatology is actively engaged in research aimed at improving the lives of patients with rheumatic diseases. Our researchers lead and collaborate on a wide range of clinical studies that assess the diagnosis, treatment and outcome of various rheumatic diseases, including:

  • inflammatory arthritis
  • lupus
  • scleroderma

They’re also involved in numerous national and international research groups, including:

  • Canadian Rheumatology Research Consortium
  • Canadian Scleroderma Research Group
  • Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus
  • Systemic Lupus International Collaborative Clinics

Our funding comes from various national and international foundations and funding agencies including The Canadian Institutes of Health Research (CIHR), The Arthritis Society of Canada, Green Shield Canada Foundation, Gardner Medical Research Trust, as well as pharmaceutical companies.


Dr. John Hanly, research director, Division of Rheumatology